miscsubjectsAI governance
Evidence review

PT-141 for IBD (Crohn's / Colitis): Evidence Review

· · 2 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-ibd`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-ibd

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-ibd/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-ibd/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-ibd/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-ibd/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have IBD (Crohn's / colitis)

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why PT-141 might help you

  1. You are reading about IBD (Crohn's / colitis) — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • PT-141 → sexual / CNS arousal

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 1
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 3

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.24 / 1.00 — low — animal and anecdote heavy

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials (source s1)

2023 review of melanocortin system in IBD; mouse models only; no PT-141 data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

The Melanocortin System in Inflammatory Bowel Diseases (source s2)

Confirms preclinical focus on related melanocortin peptides, not PT-141.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Bremelanotide (subcutaneous route) (source s3)

Official indication confirms CNS/arousal focus.

Evidence type: Published research.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

IBD / Crohn / colitis · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedPT-141: Brain-Level Arousal · 17 humanPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood… · 8 humanPT-141 for Chemotherapy Side Effects: Evidence on Sexual Arousal Pathw… · 3 humanPT-141 for Diabetic Neuropathy: Evidence-Graded Review · 3 human
Evidence · 3 sources · swipe →chain f38dd572a450 · verify chain · provenance
1 / 3
Evidence ledger 3 · tier-ranked · API
human
No human trials test PT-141 in IBD patients.
sources: s1
preclinical
A 2023 review examined melanocortin system effects in mouse colitis models but did not test PT-141.
sources: s2, s1
mechanisticlow confidence
PT-141 primary actions center on CNS melanocortin receptors for arousal rather than gut tissue repair.
sources: s3
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:15
PT-141 for IBD (Crohn's / Colitis): Evidence Review · 3 claims · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: PT 141 for Ibd
Slug: pt-141-ibd
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"IBD (Crohn's / colitis)","condition_key":"ibd-crohns-colitis","primary_peptide":"pt-141","peptides_in_scope":[{"id":"pt-141","name":"PT-141"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down if you ha
it output
{"slug":"pt-141-ibd","title":"PT-141 for IBD (Crohn's / Colitis): Evidence Review","body":"## What's breaking down if you have IBD (Crohn's / colitis)\n\nIBD involves ongoing gut lining damage. The intestinal barrier loses integrity. Immune cells release excess inflammatory signals. Tissue repair lags behind repeated injury. This cycle keeps symptoms active.\n\nLayers include epithelial breakdown, cytokine imbalance favoring inflammation, and disrupted mucosal healing. Mechanical or symptom-masking approaches may ease pressure short-term but do not address the core repair deficit.\n\n## Why PT-141 might help you\n\n1. You are reading about IBD (Crohn's / colitis) — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts on melanocortin receptors in the central nervous system and periphery. If melanocortin pathways influence gut inflammation or repair signals in your case, the compound could intersect those routes. This remains a mechanistic link only. No direct mapping to IBD symptom relief exists in studied data.\n\n## How these fit together\n\nSingle-compound focus — PT-141 targets sexual / CNS arousal pathways. If your condition profile includes a multi-peptide stack, siblings would target other layers such as direct tiss
c13f8f9d9188c0f2
Machine verification: /api/articles/pt-141-ibd/contributions

Latest from the journal

Most recent pieces, site-wide

All articles →
The Disc Stackposted 2026-07-24the-disc-stackHerniated Discposted 2026-07-24herniated-discDegenerative Disc Diseaseposted 2026-07-24degenerative-disc-diseaseBPC-157 vs NSAIDs: Repair or Suppress?posted 2026-07-24bpc-157-vs-nsaidsAgentKit: a post-mortem in advanceposted 2026-07-24what-agentkit-was

Related articles

IBD / Crohn / colitis · condition map

Open evidence map →
PT-141: Brain-Level Arousalpt-141PT-141 and Benzodiazepine Withdrawal: A Data-First Evidence Reviewpt-141-benzo-withdrawalPT-141 and Benzodiazepines: Evidence Review on CNS Arousal Layerspt-141-benzodiazepinesPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood…pt-141-blood-pressure-medsPT-141 for Statin-Associated Cognitive Effects: Evidence Reviewpt-141-brain-fogPT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Reviewpt-141-carpal-tunnel
Ask this article · 5 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "No human trials test PT-141 in IBD patients."?
ask pt-141-ibd claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "A 2023 review examined melanocortin system effects in mouse colitis models but did not test PT-141."?
ask pt-141-ibd claim c2 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "PT-141 primary actions center on CNS melanocortin receptors for arousal rather than gut tissue repair."?
ask pt-141-ibd claim c3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about PT-141 for IBD (Crohn's / Colitis): Evidence Review — and what would you need me to tell you first?
ask pt-141-ibd condition gaps · paste includes §SELF
What good and bad outcomes are documented for PT-141 for IBD (Crohn's / Colitis): Evidence Review (studies vs anecdotes)?
ask pt-141-ibd good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →